Previously, we demonstrated that downmodulation of UHRF1 (ubiquitin‐like with PHD and RING finger domains 1) in RB cells enhances the sensitivity to standard chemotherapeutic drugs such as etoposide by impairing DNA repair and consequently resulting in more robust apoptotic cell death (He et al., 2018). The gene discussed is UHRF1; the disease is retinoblastoma.